Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responses

Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responses

Group 2 innate lymphoid cells (ILC2s) are essential for orchestrating type 2 immune responses during allergic airway inflammation and infection. ILC2s have been reported to play a regulatory role in tumors; however, this conclusion is controversial. In this study, we showed that IL-33-activated ILC2...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Wen, Shipeng Cheng, Ran Wang, Yuying Huang, Long Xu, Liyan Ma, Zhiyang Ling, Jinfu Xu, Deping Zhao, Yaguang Zhang, Bing Sun
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
anti-tumor response
antigen presentation
CD8 T cell
ILC2
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2243112
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2023.2243112

Similar Items